Trademark Overview

---

On Thursday, March 29, 2001, a trademark application was filed for NEOLIPID with the United States Patent and Trademark Office. The USPTO has given the NEOLIPID trademark a serial number of 76231838. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 17, 2012. This trademark is owned by NeoPharm, Inc.. The NEOLIPID trademark is filed in the Pharmaceutical Products category with the following description:

Liposome platform used in drug delivery

General Information

---

Serial Number	76231838
Word Mark	NEOLIPID
Filing Date	Thursday, March 29, 2001
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, February 17, 2012
Registration Number	2967441
Registration Date	Tuesday, July 12, 2005
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, December 4, 2001

Trademark Statements

---

Goods and Services

Liposome platform used in drug delivery

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, February 17, 2012
Primary Code	005
First Use Anywhere Date	Tuesday, January 6, 2004
First Use In Commerce Date	Tuesday, January 6, 2004

Trademark Owner History

---

Party Name	NeoPharm, Inc.
Party Type	30 - Original Registrant
Legal Entity Type	03 - Corporation
Address	Lake Forest, IL 60045

---

Party Name	NeoPharm, Inc.
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	Lake Forest, IL 60045

---

Party Name	NeoPharm, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Lake Forest, IL 60045

Trademark Events

---

Event Date	Event Description
Friday, February 17, 2012	CANCELLED SEC. 8 (6-YR)
Thursday, March 22, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 22, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2005	REGISTERED-PRINCIPAL REGISTER
Monday, April 18, 2005	LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 15, 2005	ASSIGNED TO LIE
Monday, April 11, 2005	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 9, 2005	STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 22, 2005	USE AMENDMENT FILED
Tuesday, February 22, 2005	TEAS STATEMENT OF USE RECEIVED
Tuesday, September 14, 2004	EXTENSION 5 GRANTED
Tuesday, August 24, 2004	EXTENSION 5 FILED
Friday, August 27, 2004	PAPER RECEIVED
Wednesday, August 25, 2004	EMAIL RECEIVED
Monday, July 19, 2004	CASE FILE IN TICRS
Wednesday, February 25, 2004	EXTENSION 4 GRANTED
Wednesday, February 11, 2004	EXTENSION 4 FILED
Wednesday, February 11, 2004	TEAS EXTENSION RECEIVED
Thursday, August 7, 2003	EXTENSION 3 GRANTED
Monday, July 21, 2003	EXTENSION 3 FILED
Monday, July 21, 2003	TEAS EXTENSION RECEIVED
Thursday, April 3, 2003	EXTENSION 2 GRANTED
Monday, February 3, 2003	EXTENSION 2 FILED
Monday, February 3, 2003	TEAS EXTENSION RECEIVED
Friday, August 16, 2002	EXTENSION 1 GRANTED
Wednesday, August 7, 2002	EXTENSION 1 FILED
Wednesday, August 7, 2002	TEAS EXTENSION RECEIVED
Tuesday, February 26, 2002	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2001	PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2001	NOTICE OF PUBLICATION
Friday, July 27, 2001	APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 12, 2001	ASSIGNED TO EXAMINER

Related Keywords

---

neolipid delivery drug used platform liposome